THe principal goal of the proposed program is the definition of critical immunopathogenetic roles of lipid and peptide mediators in human hypersensitivity states. The molecular and cellular components of abnormal reactions to a variety of environmental and endogenous stimuli will be studied in relation to the mechanisms responsible for excessive production of the mediators and for both functional hyperreactivity of organ systems and unregulated responses of leukocytes and platelets to the mediators. Core laboratories will be established for the performance of reliable standardized assays of leukocyte and platelet function, the purification and quantification of lipid principles in cells and biological fluids, and the determination of the characteristics of cellular receptors for lipid and peptide mediators. Previously developed methods will be adapted in the core laboratories to studies of human immunological diseases and animal models of such diseases. Specific investigations will be directed to the elucidation of the involvement of leukotrienes in hypersensitivity reactions to aspirin, related compounds, and food additives and the participation of leukotrienes and phospholipid mediators in the activation of leukocytes and platelets in adverse responses to radiographic contrast media. The roles of lipid and peptide mediators in the modulation of regulatory subsets of T-lymphocytes will be assessed in relation to seasonal allergies and responses to immunotherapy. The lipid mediators of the vascular reactions in cold urticaria and of the leukocytic components of bullous pemphigoid will be characterized by examining materials collected from patients with elicited attacks or spontaneous episodes of the diseases. The involvement of mast cell-derived mediators in the airway hyperreactivity of natively allergic dogs will be evaluated by analyzing the spectrum of lipid principles generated by canine mastocytoma cells and lung tissue mast cells challenged with IgE-dependent stimuli. The possibilities of endogenous regulation and pharmacological control of the mediators will be assessed in relation to the central mechanisms responsible for each of the allergic, dermatological, and pulmonary hypersensitivity states.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
3P01AI019784-03S1
Application #
3091575
Study Section
Allergy and Immunology Research Committee (AIRC)
Project Start
1983-09-01
Project End
1986-11-30
Budget Start
1986-09-01
Budget End
1986-11-30
Support Year
3
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Valone, F H; Ruis, N M (1992) Stimulation of tumour necrosis factor release by cytotoxic analogues of platelet-activating factor. Immunology 76:24-9
Goldman, D W; Gifford, L A; Young, R N et al. (1991) Affinity labeling of the membrane protein-binding component of human polymorphonuclear leukocyte receptors for leukotriene B4. J Immunol 146:2671-7
Ruis, N M; Rose, J K; Valone, F H (1991) Tumor necrosis factor release by human monocytes stimulated with platelet-activating factor. Lipids 26:1060-4
Barthelson, R A; Valone, F H (1991) Platelet-activating factor stimulates expression of IL-1 beta mRNA in THP-1 cells. Lipids 26:257-60
Adolff, C H; Golden, J A; Kennedy, P W et al. (1991) Polymerase chain reaction amplification of messages for growth factors in cells from human bronchoalveolar lavage fluids. Inflammation 15:259-68
Barthelson, R A; Potter, T; Valone, F H (1990) Synergistic increases in IL-1 synthesis by the human monocytic cell line THP-1 treated with PAF and endotoxin. Cell Immunol 125:142-50
Barthelson, R; Valone, F (1990) Interaction of platelet-activating factor with interferon-gamma in the stimulation of interleukin-1 production by human monocytes. J Allergy Clin Immunol 86:193-201
Rangi, S P; Serwonska, M H; Lenahan, G A et al. (1990) Suppression by ingested eicosapentaenoic acid of the increases in nasal mucosal blood flow and eosinophilia of ryegrass-allergic reactions. J Allergy Clin Immunol 85:484-9
Goetzl, E J; Adelman, D C; Sreedharan, S P (1990) Neuroimmunology. Adv Immunol 48:161-90
Rangi, S P; Sample, S; Serwonska, M H et al. (1990) Mediation of prolonged increases in nasal mucosal blood flow by calcitonin gene-related peptide (CGRP). J Clin Immunol 10:304-10

Showing the most recent 10 out of 90 publications